Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

12.53 

0.37 3.0%

as of Mar 26 '19

52 Week Range:

12.16 16.69


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Nikon Corporation manufactures and sells optical instruments in Japan and internationally. It operates through three segments: Imaging Products Business, Precision Equipment Business, and Healthcare Business. The Imaging Products Business segment develops, manufacture, sells and service of digital cameras–interchangeable lens type, interchangeable lenses and compact digital cameras, and other products. The Precision Equipment Business segment develops, manufacture, sells and service of FPD lithography systems for the production of LCD and organic light-emitting diode panels; and semiconductor lithography systems for the production of semiconductors used primarily in electronics. The Healthcare Business segment develops, manufactures, sells, and services biological microscopes, cell culture observation systems, ultra-wide field retinal imaging devices, etc. This segment also engages in the regenerative medicine contract manufacturing business. The company is also involved in the development, manufacturing, sale, and service of industrial microscopes, measuring instruments, X-ray/CT inspection systems, metrology systems, and surveying instruments' and customized products, glass, encoders, and ophthalmic lenses businesses, as well as sale of photomask substrates for FPD and optical materials.Nikon Corporation has a strategic alliance with Verily Life Sciences LLC in the field of machine learning-enabled retinal imaging. The company was formerly known as Nippon Kogaku K.K. and changed its name to Nikon Corporation in 1988. Nikon Corporation was founded in 1917 and is headquartered in Tokyo, Japan.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Equity (BVPS) 6.24
7.28
7.54
8.36
9.43
9.61
9.76
11.13
11.30
11.17
11.02
growth rate 16.7% 3.6% 10.9% 12.8% 1.9% 1.6% 14.0% 1.5% -1.2% -1.3%
Earnings BIT 840.24
282.10
-127.22
334.87
620.42
445.39
62,942.00
43,413.00
36,702.00
58,038.00
65,006.00
growth rate -66.4% -100.0% 100.0% 85.3% -28.2% 14,031.8% -31.0% -15.5% 58.1% 12.0%
Avg.PE 14.27
16.08
0.00
24.45
16.61
20.33
12.77
12.77
-87.27
21.86
growth rate 12.7% -100.0% -32.1% 22.4% -20.7% 0.0% -100.0% 100.0%
ROA 9.62
3.57
-1.69
3.48
7.02
4.92
5.16
1.91
2.31
0.40
3.29
growth rate -62.9% -100.0% 100.0% 101.7% -29.9% 4.9% -63.0% 20.9% -82.7% 722.5%
ROE 20.36
7.27
-3.36
7.18
14.41
9.18
9.02
3.28
3.99
0.74
6.26
growth rate -64.3% -100.0% 100.0% 100.7% -36.3% -1.7% -63.6% 21.7% -81.5% 746.0%
ROIC 17.66
5.83
-2.48
5.79
11.91
7.82
7.53
2.69
3.25
0.60
5.06
growth rate -67.0% -100.0% 100.0% 105.7% -34.3% -3.7% -64.3% 20.8% -81.5% 743.3%
Cur. Ratio 1.69
1.79
1.62
1.73
1.78
1.92
2.32
2.39
2.25
1.93
1.94
growth rate 5.9% -9.5% 6.8% 2.9% 7.9% 20.8% 3.0% -5.9% -14.2% 0.5%
Quick Ratio 0.78
0.70
0.74
0.89
0.79
0.82
1.26
1.37
1.21
1.24
1.29
growth rate -10.3% 5.7% 20.3% -11.2% 3.8% 53.7% 8.7% -11.7% 2.5% 4.0%
Leverage 2.09
1.98
1.99
2.13
1.98
1.76
1.74
1.70
1.75
1.89
1.92
growth rate -5.3% 0.5% 7.0% -7.0% -11.1% -1.1% -2.3% 2.9% 8.0% 1.6%
Balance Sheet Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Acct.Receivable 156,893.00
114,150.00
105,445.00
115,712.00
132,866.00
130,430.00
124,474.00
127,395.00
96,557.00
96,221.00
104,526.00
growth rate -27.2% -7.6% 9.7% 14.8% -1.8% -4.6% 2.4% -24.2% -0.4% 8.6%
Acct.Payable 124,676.00
118,841.00
113,724.00
117,399.00
112,870.00
118,701.00
growth rate -4.7% -4.3% 3.2% -3.9% 5.2%
Cur.Assets 596,114.00
518,935.00
484,624.00
590,954.00
609,474.00
575,647.00
648,822.00
685,516.00
661,646.00
659,013.00
754,182.00
growth rate -13.0% -6.6% 21.9% 3.1% -5.6% 12.7% 5.7% -3.5% -0.4% 14.4%
Total Assets 820,614.00
5,323.62
5,332.55
5,975.34
6,193.66
865,019.00
949,515.00
972,945.00
945,827.00
1,018,351.00
1,098,343.00
growth rate -99.4% 0.2% 12.1% 3.7% 13,866.2% 9.8% 2.5% -2.8% 7.7% 7.9%
Cash 113,973.00
570.49
775.30
1,303.75
953.31
110,281.00
225,519.00
262,501.00
256,595.00
319,046.00
388,438.00
growth rate -99.5% 35.9% 68.2% -26.9% 11,468.2% 104.5% 16.4% -2.3% 24.3% 21.8%
Inventory 264,719.00
265,213.00
206,994.00
236,405.00
263,033.00
269,411.00
244,941.00
239,981.00
247,446.00
220,400.00
235,553.00
growth rate 0.2% -22.0% 14.2% 11.3% 2.4% -9.1% -2.0% 3.1% -10.9% 6.9%
Cur.Liabilities 352,460.00
289,335.00
299,827.00
342,295.00
342,009.00
299,186.00
280,176.00
287,265.00
294,424.00
341,918.00
389,756.00
growth rate -17.9% 3.6% 14.2% -0.1% -12.5% -6.4% 2.5% 2.5% 16.1% 14.0%
Liabilities 427,490.00
2,632.10
2,653.65
3,172.96
3,071.62
373,696.00
402,703.00
400,746.00
404,820.00
480,201.00
524,802.00
growth rate -99.4% 0.8% 19.6% -3.2% 12,066.1% 7.8% -0.5% 1.0% 18.6% 9.3%
LT Debt 60,212.00
465.49
295.96
491.90
474.14
62,600.00
99,600.00
84,600.00
84,200.00
114,476.00
113,139.00
growth rate -99.2% -36.4% 66.2% -3.6% 13,102.8% 59.1% -15.1% -0.5% 36.0% -1.2%
Equity 393,123.00
2,691.51
2,678.90
2,802.38
3,122.04
3,537.53
546,725.00
571,692.00
540,477.00
537,524.00
572,908.00
growth rate -99.3% -0.5% 4.6% 11.4% 13.3% 15,355.0% 4.6% -5.5% -0.6% 6.6%
Common Shares 417.00
413.00
396.00
397.00
397.00
397.00
397.00
397.00
397.00
397.00
397.00
growth rate -1.0% -4.1% 0.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Capital Expenditures 28,433.00
216.18
237.70
159.57
248.18
61,855.00
32,680.00
22,337.00
21,957.00
21,295.00
28,062.00
growth rate -99.2% 10.0% -32.9% 55.5% 24,823.0% -47.2% -31.7% -1.7% -3.0% 31.8%
Cash Dividends 9,187.00
73.40
27.15
25.73
88.40
114.06
8,721.00
12,685.00
11,910.00
8,734.00
7,153.00
growth rate -99.2% -63.0% -5.3% 243.6% 29.0% 7,546.3% 45.5% -6.1% -26.7% -18.1%
Cash From OA 121,309.00
71.80
745.18
890.01
108.53
51,890.00
114,185.00
71,309.00
105,214.00
97,342.00
125,082.00
growth rate -99.9% 937.9% 19.4% -87.8% 47,713.6% 120.1% -37.6% 47.6% -7.5% 28.5%
FCF per Share 1.47
-0.39
1.41
2.16
0.70
-1.09
0.99
1.41
1.85
1.84
1.34
growth rate -100.0% 100.0% 53.2% -67.6% -100.0% 100.0% 42.4% 31.2% -0.5% -27.2%
FCF 92,406.00
-20,922.00
69,862.00
100,728.00
-20,700.00
-9,965.00
81,505.00
48,972.00
83,257.00
66,928.00
89,348.00
growth rate -100.0% 100.0% 44.2% -100.0% 0.0% 100.0% -39.9% 70.0% -19.6% 33.5%
Income Statement Mar '08 Mar '09 Mar '10 Mar '11 Mar '12 Mar '13 Mar '14 Mar '15 Mar '16 Mar '17 Mar '18
Sales 955,791.00
6,246.00
5,655.59
6,390.09
6,614.29
1,010,493.00
980,556.00
857,782.00
822,915.00
749,273.00
717,078.00
growth rate -99.4% -9.5% 13.0% 3.5% 15,177.4% -3.0% -12.5% -4.1% -9.0% -4.3%
Op.Income 124,597.00
342.11
-99.75
389.17
576.58
42,459.00
62,942.00
43,413.00
36,702.00
58,038.00
65,006.00
growth rate -99.7% -100.0% 100.0% 48.2% 7,264.0% 48.2% -31.0% -15.5% 58.1% 12.0%
IBT 116,707.00
278.18
-127.23
334.84
620.41
445.36
74,690.00
35,152.00
33,580.00
3,068.00
56,257.00
growth rate -99.8% -100.0% 100.0% 85.3% -28.2% 16,670.6% -52.9% -4.5% -90.9% 1,733.7%
Net Income 75,487.00
199.19
-90.83
196.65
427.00
42,459.00
46,824.00
18,364.00
22,192.00
3,967.00
34,772.00
growth rate -99.7% -100.0% 100.0% 117.1% 9,843.7% 10.3% -60.8% 20.9% -82.1% 776.5%
EPS 181.23
67.91
-31.82
68.83
149.41
106.92
117.88
46.21
75.37
9.98
87.49
growth rate -62.5% -100.0% 100.0% 117.1% -28.4% 10.3% -60.8% 63.1% -86.8% 776.7%
Gross Profit 398,791.00
2,258.34
1,678.25
2,246.23
2,531.89
346,984.00
349,988.00
325,399.00
317,618.00
306,120.00
312,908.00
growth rate -99.4% -25.7% 33.8% 12.7% 13,604.6% 0.9% -7.0% -2.4% -3.6% 2.2%
R&D 74,552.00
66,730.00
66,780.00
61,114.00
58,655.00
growth rate -10.5% 0.1% -8.5% -4.0%

Quarterly Statements

Item Name Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Earnings BIT 18,475.00
23,515.00
19,004.00
11,637.00
21,913.00
growth rate 27.3% -19.2% -38.8% 88.3%
Balance Sheet Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Acct.Receivable 108,464.00
104,526.00
98,363.00
94,619.00
101,717.00
growth rate -3.6% -5.9% -3.8% 7.5%
Acct.Payable 120,669.00
118,701.00
119,026.00
117,428.00
117,150.00
growth rate -1.6% 0.3% -1.3% -0.2%
Cur.Assets 771,836.00
754,182.00
782,746.00
800,804.00
804,882.00
growth rate -2.3% 3.8% 2.3% 0.5%
Total Assets 1,132,033.00
1,098,343.00
1,130,415.00
1,157,099.00
1,146,822.00
growth rate -3.0% 2.9% 2.4% -0.9%
Cash 386,655.00
388,438.00
407,576.00
415,170.00
415,622.00
growth rate 0.5% 4.9% 1.9% 0.1%
Inventory 249,142.00
235,553.00
248,769.00
262,320.00
264,267.00
growth rate -5.5% 5.6% 5.5% 0.7%
Cur.Liabilities 418,981.00
389,756.00
412,459.00
421,888.00
424,503.00
growth rate -7.0% 5.8% 2.3% 0.6%
Liabilities 557,029.00
524,802.00
548,832.00
559,238.00
560,044.00
growth rate -5.8% 4.6% 1.9% 0.1%
LT Debt 114,605.00
113,139.00
114,083.00
114,752.00
114,002.00
growth rate -1.3% 0.8% 0.6% -0.7%
Equity 574,290.00
572,908.00
580,948.00
597,145.00
586,028.00
growth rate -0.2% 1.4% 2.8% -1.9%
Common Shares 65,476.00
65,476.00
65,476.00
65,476.00
65,476.00
growth rate 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Capital Expenditures 5,481.00
9,480.00
5,582.00
6,768.00
4,085.00
growth rate 73.0% -41.1% 21.3% -39.6%
Cash Dividends 5,428.00
126.00
8,549.00
177.00
11,654.00
growth rate -97.7% 6,684.9% -97.9% 6,484.2%
Cash From OA 68,266.00
32,332.00
35,470.00
16,358.00
19,094.00
growth rate -52.6% 9.7% -53.9% 16.7%
FCF 62,785.00
22,852.00
29,888.00
9,590.00
15,009.00
growth rate -63.6% 30.8% -67.9% 56.5%
Income Statement Dec '17 Mar '18 Jun '18 Sep '18 Dec '18
Sales 196,813.00
191,816.00
166,905.00
168,843.00
190,522.00
growth rate -2.5% -13.0% 1.2% 12.8%
Op.Income 18,475.00
23,515.00
19,004.00
11,637.00
21,913.00
growth rate 27.3% -19.2% -38.8% 88.3%
IBT 18,881.00
15,920.00
21,930.00
11,961.00
23,123.00
growth rate -15.7% 37.8% -45.5% 93.3%
Net Income 8,364.00
12,463.00
16,338.00
6,484.00
17,958.00
growth rate 49.0% 31.1% -60.3% 177.0%
EPS
growth rate
Gross Profit 89,396.00
84,243.00
75,108.00
71,931.00
82,344.00
growth rate -5.8% -10.8% -4.2% 14.5%
R&D 58,655.00
58,655.00
growth rate 0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

D (43.75)

YOY Growth Grade:

E (17.52)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 12.57 12.57 16.53
EPS / Growth -63.5% 1.00 97.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 50.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 49.6% 53.6%
Future PE 2.00 15.21 45.42
Future EPS 1.10 55.87 72.79
Value Price
MOS %
0.54
-95.7%
210.03
1,576.3%
817.17
6,421.7%
MOS Price 0.27 105.02 408.58
IRT 11.79 4.06 3.91

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.